The largest database of trusted experimental protocols

Quick imaging system

Manufactured by Olympus
Sourced in United States

The Quick Imaging system is a laboratory equipment designed for rapid image capture and analysis. It provides a fast and efficient way to acquire high-quality images of samples. The core function of the system is to enable quick and precise image acquisition for various scientific and research applications.

Automatically generated - may contain errors

9 protocols using quick imaging system

1

Cell Proliferation Analysis of H9c2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation analysis was performed by taking pictures as described (Chen et al., 2014 (link)). Briefly, H9c2 cells were seeded in DMEM supplemented with 10% FBS in 6-well plates at a density of 2 × 105 cells/well and grown overnight at 37°C in a humidified incubator with 5% CO2. The next day, maduramicin (0–1 μg/ml) was added. In some cases, cells were pretreated with okadaic acid for 1 h or infected with Ad-MKK1-R4F, Ad-dn-PP2A and Ad-GFP for 24 h. Then maduramicin (0.5 and 1 μg/ml) was added. After incubation for 48 h, images were taken with an Olympus inverted phase-contrast microscope equipped with the Quick Imaging system.
+ Open protocol
+ Expand
2

Evaluating FC101 Cytotoxicity in COS7 and HEK 293

Check if the same lab product or an alternative is used in the 5 most similar protocols
COS7 and HEK 293 cells were seeded at a density of 2×104 cells per well in 6-well plates. The next day, FC101 (0–5 µM) was added. After incubation for 4–6 days until the control cells were nearly 100% confluent, images were taken with an Olympus inverted phase-contrast microscope equipped with the Quick Imaging system. All cells were then trypsinized and enumerated using a Z1 Coulter Counter (Beckman Coulter, Fullerton, CA). Cells treated with vehicle alone (phosphate buffered saline, PBS) were used as a control.
+ Open protocol
+ Expand
3

Evaluation of FC101 and Pathway Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a density of 2 × 105 cells/well in a 6-well plate. The next day, cells were treated with FC101 (0–1 μM), following pre-incubation with/without SP600125 (1 μM) for 30 min. In some cases, after infection with Ad-PP2A, Ad-PP5 and Ad-GFP, respectively, cells were exposed to FC101 (0–1 μM) for 24 h. Additionally, cells were seeded at a density of 2 × 104 cells/well in a 6-well plate. The next day, the cells were exposed to FC101 (0–1 μM) for 4–6 days following pretreatment with or without NAC (5 mM) for 1 h. Finally, images were taken with an Olympus inverted phase-contrast microscope equipped with the Quick Imaging system.
+ Open protocol
+ Expand
4

Maduramicin Inhibits Cell Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell growth was analyzed as described (Chen et al. 2014 (link)). Briefly, cells, seeded in 6-well plates, were treated with maduramicin (0–1 μg/ml). In some cases, C2C12 cells were pretreated with SP600125 or NAC for 1 h or infected with Ad-dn-c-Jun, Ad-PP5 and Ad-GFP for 24h, then exposed to maduramicin (0.5 and 1 μg/ml). After incubation for 48 h, images were taken with an Olympus inverted phase-contrast microscope equipped with the Quick Imaging system. The cells were then trypsinized and enumerated using a Z1 Coulter Counter (Beckman Coulter, Fullerton, CA, USA).
+ Open protocol
+ Expand
5

Cell Morphology and Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell morphological analysis and cell proliferation assay were performed as described [24] (link). Briefly, cells were seeded in 6-well plates at a density of 1×104 cells/well and cultured in the growth medium overnight at 37°C in a humidified incubator with 5% CO2. The next day, maduramicin (0–1 µg/ml) was added. After incubation for 5 days, images were taken with an Olympus inverted phase-contrast microscope equipped with the Quick Imaging system. The cells were then trypsinized and enumerated using a Z1 Coulter Counter (Beckman Coulter, Fullerton, CA, USA). Cells treated with the vehicle (DMSO) alone served as a control.
+ Open protocol
+ Expand
6

Celastrol-Induced Cell Morphology Changes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a density of 1 × 106 cells/well in a six-well plate. Next day, 0.5 μM celastrol was added. After 24 h, images were taken with an Olympus inverted phase-contrast microscope (Olympus Optical Co., Melville, NY, USA) (200×) equipped with the Quick Imaging system.
+ Open protocol
+ Expand
7

Evaluating CPX Effects on Rh30 and RD Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rh30 and RD cells were seeded in 6-well plates (2 × 105 cells/well). The next day, the cells were treated with CPX (0, 5 and 20 μM). After incubation for 72 h, images were taken with an Olympus inverted phase-contrast microscope (Olympus Optical Co., Melville, NY) (200×) equipped with the Quick Imaging system.
+ Open protocol
+ Expand
8

Brevinin-1RL1 Inhibits A549 and HCT116 Cell Growth

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 and HCT116 cells were seeded (1 × 105 cells/well) in complete culture medium. The next day, the cells were treated with Brevinin-1RL1 (0, 6 and 12 μM) for 24 h, images were taken with an Olympus inverted phasecontrast microscope (Olympus Optical Co., Melville, NY, USA) (200×) equipped with the Quick Imaging system.
+ Open protocol
+ Expand
9

Neuroprotective Effects of Rapamycin

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC12 cells, SH-SY5Y cells and primary neurons were seeded in a PDL-uncoated or -coated 6-well plate (5 × 105 cells/well) or 96-well plate (1 × 104 cells/well). The next day, the cells were exposed to Cd (10 and/or 20 μM) for 24 h following pre-incubation with/without rapamycin (200 ng/ml) for 48 h, with 5 replicates of each treatment. Subsequently, the images for morphological analysis were taken under an Olympus inverted phase-contrast microscope (Olympus Optical Co., Melville, NY, USA) (200 ×) equipped with the Quick Imaging system. Caspase-3/7 activity was determined using Caspase-Glo® 3/7 Assay Kit (Promega, Madison, WI, USA), following the instructions of the supplier.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!